カテゴリ： 世界, 医療/バイオ, QYResearch

腎皮質壊死治療の世界市場2023年：プレドニゾロン、アスピリン、炭酸水素ナトリウム、N-アセチルシステイン、スタチン、その他

■ 英語タイトル：Global Renal Cortical Necrosis Treatment Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8323）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8323
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：87
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[腎皮質壊死治療の世界市場2023年：プレドニゾロン、アスピリン、炭酸水素ナトリウム、N-アセチルシステイン、スタチン、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は腎皮質壊死治療のグローバル市場について調査・分析し、世界の腎皮質壊死治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（プレドニゾロン、アスピリン、炭酸水素ナトリウム、N-アセチルシステイン、スタチン、その他）、用途別セグメント分析（病院、がんクリニック、外来手術センター、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Allergan plc、Amgen Inc.、AstraZeneca plc、Baxter、Keryx Biopharmaceuticals, Inc、Teva Pharmaceutical Limited Inc、Pfizer、Novartis AG、Eisai Pharmaceuticals India Pvt. Ltd.などが含まれています。腎皮質壊死治療のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、腎皮質壊死治療市場規模を算出する際に考慮しました。

・腎皮質壊死治療市場の概要
- 腎皮質壊死治療の種類別セグメント
- 世界の腎皮質壊死治療市場規模：タイプ別分析（プレドニゾロン、アスピリン、炭酸水素ナトリウム、N-アセチルシステイン、スタチン、その他）
- 腎皮質壊死治療の用途別セグメント
- 世界の腎皮質壊死治療市場規模：用途別分析（病院、がんクリニック、外来手術センター、その他）
- 世界の腎皮質壊死治療市場規模予測（2018年-2029年）

・腎皮質壊死治療市場の成長トレンド
- 腎皮質壊死治療の地域別市場規模（2018年-2029年）
- 腎皮質壊死治療市場ダイナミクス
- 腎皮質壊死治療の業界動向
- 腎皮質壊死治療市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：プレドニゾロン、アスピリン、炭酸水素ナトリウム、N-アセチルシステイン、スタチン、その他
- 世界の腎皮質壊死治療のタイプ別市場規模（2018年-2023年）
- 世界の腎皮質壊死治療のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、がんクリニック、外来手術センター、その他
- 世界の腎皮質壊死治療の用途別市場規模（2018年-2023年）
- 世界の腎皮質壊死治療の用途別市場規模（2024年-2029年）

・腎皮質壊死治療の地域別市場規模
- 北米の腎皮質壊死治療市場規模（2018年-2029年）
- 米国の腎皮質壊死治療市場規模（2018年-2029年）
- ヨーロッパの腎皮質壊死治療市場規模（2018年-2029年）
- アジア太平洋の腎皮質壊死治療市場規模（2018年-2029年）
- 中国の腎皮質壊死治療市場規模（2018年-2029年）
- 日本の腎皮質壊死治療市場規模（2018年-2029年）
- 韓国の腎皮質壊死治療市場規模（2018年-2029年）
- インドの腎皮質壊死治療市場規模（2018年-2029年）
- オーストラリアの腎皮質壊死治療市場規模（2018年-2029年）
- 中南米の腎皮質壊死治療市場規模（2018年-2029年）
- 中東・アフリカの腎皮質壊死治療市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Allergan plc、Amgen Inc.、AstraZeneca plc、Baxter、Keryx Biopharmaceuticals, Inc、Teva Pharmaceutical Limited Inc、Pfizer、Novartis AG、Eisai Pharmaceuticals India Pvt. Ltd.

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Renal Cortical Necrosis Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Renal Cortical Necrosis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Renal Cortical Necrosis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Renal Cortical Necrosis Treatment in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Renal Cortical Necrosis Treatment include Allergan plc, Amgen Inc., AstraZeneca plc, Baxter, Keryx Biopharmaceuticals, Inc, Teva Pharmaceutical Limited Inc, Pfizer, Novartis AG and Eisai Pharmaceuticals India Pvt. Ltd., etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Renal Cortical Necrosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Renal Cortical Necrosis Treatment.
The Renal Cortical Necrosis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Renal Cortical Necrosis Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Renal Cortical Necrosis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Allergan plc
Amgen Inc.
AstraZeneca plc
Baxter
Keryx Biopharmaceuticals, Inc
Teva Pharmaceutical Limited Inc
Pfizer
Novartis AG
Eisai Pharmaceuticals India Pvt. Ltd.
Segment by Type
Prednisolone
Aspirin
Sodium Bicarbonates
N-acetyl Cysteine
Statins
Others
Segment by Application
Hospitals
Cancer clinics
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Renal Cortical Necrosis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Renal Cortical Necrosis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Prednisolone
1.2.3 Aspirin
1.2.4 Sodium Bicarbonates
1.2.5 N-acetyl Cysteine
1.2.6 Statins
1.2.7 Others
1.3 Market by Application
1.3.1 Global Renal Cortical Necrosis Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Cancer clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Renal Cortical Necrosis Treatment Market Perspective (2018-2029)
2.2 Renal Cortical Necrosis Treatment Growth Trends by Region
2.2.1 Global Renal Cortical Necrosis Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Renal Cortical Necrosis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Renal Cortical Necrosis Treatment Forecasted Market Size by Region (2024-2029)
2.3 Renal Cortical Necrosis Treatment Market Dynamics
2.3.1 Renal Cortical Necrosis Treatment Industry Trends
2.3.2 Renal Cortical Necrosis Treatment Market Drivers
2.3.3 Renal Cortical Necrosis Treatment Market Challenges
2.3.4 Renal Cortical Necrosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Renal Cortical Necrosis Treatment Players by Revenue
3.1.1 Global Top Renal Cortical Necrosis Treatment Players by Revenue (2018-2023)
3.1.2 Global Renal Cortical Necrosis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Renal Cortical Necrosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Renal Cortical Necrosis Treatment Revenue
3.4 Global Renal Cortical Necrosis Treatment Market Concentration Ratio
3.4.1 Global Renal Cortical Necrosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Renal Cortical Necrosis Treatment Revenue in 2022
3.5 Renal Cortical Necrosis Treatment Key Players Head office and Area Served
3.6 Key Players Renal Cortical Necrosis Treatment Product Solution and Service
3.7 Date of Enter into Renal Cortical Necrosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Renal Cortical Necrosis Treatment Breakdown Data by Type
4.1 Global Renal Cortical Necrosis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Renal Cortical Necrosis Treatment Forecasted Market Size by Type (2024-2029)
5 Renal Cortical Necrosis Treatment Breakdown Data by Application
5.1 Global Renal Cortical Necrosis Treatment Historic Market Size by Application (2018-2023)
5.2 Global Renal Cortical Necrosis Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Renal Cortical Necrosis Treatment Market Size (2018-2029)
6.2 North America Renal Cortical Necrosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Renal Cortical Necrosis Treatment Market Size by Country (2018-2023)
6.4 North America Renal Cortical Necrosis Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Renal Cortical Necrosis Treatment Market Size (2018-2029)
7.2 Europe Renal Cortical Necrosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Renal Cortical Necrosis Treatment Market Size by Country (2018-2023)
7.4 Europe Renal Cortical Necrosis Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Renal Cortical Necrosis Treatment Market Size (2018-2029)
8.2 Asia-Pacific Renal Cortical Necrosis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Renal Cortical Necrosis Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Renal Cortical Necrosis Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Renal Cortical Necrosis Treatment Market Size (2018-2029)
9.2 Latin America Renal Cortical Necrosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Renal Cortical Necrosis Treatment Market Size by Country (2018-2023)
9.4 Latin America Renal Cortical Necrosis Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Renal Cortical Necrosis Treatment Market Size (2018-2029)
10.2 Middle East & Africa Renal Cortical Necrosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Renal Cortical Necrosis Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Renal Cortical Necrosis Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan plc
11.1.1 Allergan plc Company Detail
11.1.2 Allergan plc Business Overview
11.1.3 Allergan plc Renal Cortical Necrosis Treatment Introduction
11.1.4 Allergan plc Revenue in Renal Cortical Necrosis Treatment Business (2018-2023)
11.1.5 Allergan plc Recent Development
11.2 Amgen Inc.
11.2.1 Amgen Inc. Company Detail
11.2.2 Amgen Inc. Business Overview
11.2.3 Amgen Inc. Renal Cortical Necrosis Treatment Introduction
11.2.4 Amgen Inc. Revenue in Renal Cortical Necrosis Treatment Business (2018-2023)
11.2.5 Amgen Inc. Recent Development
11.3 AstraZeneca plc
11.3.1 AstraZeneca plc Company Detail
11.3.2 AstraZeneca plc Business Overview
11.3.3 AstraZeneca plc Renal Cortical Necrosis Treatment Introduction
11.3.4 AstraZeneca plc Revenue in Renal Cortical Necrosis Treatment Business (2018-2023)
11.3.5 AstraZeneca plc Recent Development
11.4 Baxter
11.4.1 Baxter Company Detail
11.4.2 Baxter Business Overview
11.4.3 Baxter Renal Cortical Necrosis Treatment Introduction
11.4.4 Baxter Revenue in Renal Cortical Necrosis Treatment Business (2018-2023)
11.4.5 Baxter Recent Development
11.5 Keryx Biopharmaceuticals, Inc
11.5.1 Keryx Biopharmaceuticals, Inc Company Detail
11.5.2 Keryx Biopharmaceuticals, Inc Business Overview
11.5.3 Keryx Biopharmaceuticals, Inc Renal Cortical Necrosis Treatment Introduction
11.5.4 Keryx Biopharmaceuticals, Inc Revenue in Renal Cortical Necrosis Treatment Business (2018-2023)
11.5.5 Keryx Biopharmaceuticals, Inc Recent Development
11.6 Teva Pharmaceutical Limited Inc
11.6.1 Teva Pharmaceutical Limited Inc Company Detail
11.6.2 Teva Pharmaceutical Limited Inc Business Overview
11.6.3 Teva Pharmaceutical Limited Inc Renal Cortical Necrosis Treatment Introduction
11.6.4 Teva Pharmaceutical Limited Inc Revenue in Renal Cortical Necrosis Treatment Business (2018-2023)
11.6.5 Teva Pharmaceutical Limited Inc Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Renal Cortical Necrosis Treatment Introduction
11.7.4 Pfizer Revenue in Renal Cortical Necrosis Treatment Business (2018-2023)
11.7.5 Pfizer Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Detail
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Renal Cortical Necrosis Treatment Introduction
11.8.4 Novartis AG Revenue in Renal Cortical Necrosis Treatment Business (2018-2023)
11.8.5 Novartis AG Recent Development
11.9 Eisai Pharmaceuticals India Pvt. Ltd.
11.9.1 Eisai Pharmaceuticals India Pvt. Ltd. Company Detail
11.9.2 Eisai Pharmaceuticals India Pvt. Ltd. Business Overview
11.9.3 Eisai Pharmaceuticals India Pvt. Ltd. Renal Cortical Necrosis Treatment Introduction
11.9.4 Eisai Pharmaceuticals India Pvt. Ltd. Revenue in Renal Cortical Necrosis Treatment Business (2018-2023)
11.9.5 Eisai Pharmaceuticals India Pvt. Ltd. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Renal Cortical Necrosis Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Prednisolone
Table 3. Key Players of Aspirin
Table 4. Key Players of Sodium Bicarbonates
Table 5. Key Players of N-acetyl Cysteine
Table 6. Key Players of Statins
Table 7. Key Players of Others
Table 8. Global Renal Cortical Necrosis Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Renal Cortical Necrosis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Renal Cortical Necrosis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Renal Cortical Necrosis Treatment Market Share by Region (2018-2023)
Table 12. Global Renal Cortical Necrosis Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 13. Global Renal Cortical Necrosis Treatment Market Share by Region (2024-2029)
Table 14. Renal Cortical Necrosis Treatment Market Trends
Table 15. Renal Cortical Necrosis Treatment Market Drivers
Table 16. Renal Cortical Necrosis Treatment Market Challenges
Table 17. Renal Cortical Necrosis Treatment Market Restraints
Table 18. Global Renal Cortical Necrosis Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Renal Cortical Necrosis Treatment Market Share by Players (2018-2023)
Table 20. Global Top Renal Cortical Necrosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Cortical Necrosis Treatment as of 2022)
Table 21. Ranking of Global Top Renal Cortical Necrosis Treatment Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Renal Cortical Necrosis Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Renal Cortical Necrosis Treatment Product Solution and Service
Table 25. Date of Enter into Renal Cortical Necrosis Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Renal Cortical Necrosis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Renal Cortical Necrosis Treatment Revenue Market Share by Type (2018-2023)
Table 29. Global Renal Cortical Necrosis Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 30. Global Renal Cortical Necrosis Treatment Revenue Market Share by Type (2024-2029)
Table 31. Global Renal Cortical Necrosis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Renal Cortical Necrosis Treatment Revenue Market Share by Application (2018-2023)
Table 33. Global Renal Cortical Necrosis Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 34. Global Renal Cortical Necrosis Treatment Revenue Market Share by Application (2024-2029)
Table 35. North America Renal Cortical Necrosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Renal Cortical Necrosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Renal Cortical Necrosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Renal Cortical Necrosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. Europe Renal Cortical Necrosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Renal Cortical Necrosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 41. Asia-Pacific Renal Cortical Necrosis Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 42. Asia-Pacific Renal Cortical Necrosis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Renal Cortical Necrosis Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 44. Latin America Renal Cortical Necrosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Latin America Renal Cortical Necrosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Renal Cortical Necrosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 47. Middle East & Africa Renal Cortical Necrosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Middle East & Africa Renal Cortical Necrosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Renal Cortical Necrosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 50. Allergan plc Company Detail
Table 51. Allergan plc Business Overview
Table 52. Allergan plc Renal Cortical Necrosis Treatment Product
Table 53. Allergan plc Revenue in Renal Cortical Necrosis Treatment Business (2018-2023) & (US$ Million)
Table 54. Allergan plc Recent Development
Table 55. Amgen Inc. Company Detail
Table 56. Amgen Inc. Business Overview
Table 57. Amgen Inc. Renal Cortical Necrosis Treatment Product
Table 58. Amgen Inc. Revenue in Renal Cortical Necrosis Treatment Business (2018-2023) & (US$ Million)
Table 59. Amgen Inc. Recent Development
Table 60. AstraZeneca plc Company Detail
Table 61. AstraZeneca plc Business Overview
Table 62. AstraZeneca plc Renal Cortical Necrosis Treatment Product
Table 63. AstraZeneca plc Revenue in Renal Cortical Necrosis Treatment Business (2018-2023) & (US$ Million)
Table 64. AstraZeneca plc Recent Development
Table 65. Baxter Company Detail
Table 66. Baxter Business Overview
Table 67. Baxter Renal Cortical Necrosis Treatment Product
Table 68. Baxter Revenue in Renal Cortical Necrosis Treatment Business (2018-2023) & (US$ Million)
Table 69. Baxter Recent Development
Table 70. Keryx Biopharmaceuticals, Inc Company Detail
Table 71. Keryx Biopharmaceuticals, Inc Business Overview
Table 72. Keryx Biopharmaceuticals, Inc Renal Cortical Necrosis Treatment Product
Table 73. Keryx Biopharmaceuticals, Inc Revenue in Renal Cortical Necrosis Treatment Business (2018-2023) & (US$ Million)
Table 74. Keryx Biopharmaceuticals, Inc Recent Development
Table 75. Teva Pharmaceutical Limited Inc Company Detail
Table 76. Teva Pharmaceutical Limited Inc Business Overview
Table 77. Teva Pharmaceutical Limited Inc Renal Cortical Necrosis Treatment Product
Table 78. Teva Pharmaceutical Limited Inc Revenue in Renal Cortical Necrosis Treatment Business (2018-2023) & (US$ Million)
Table 79. Teva Pharmaceutical Limited Inc Recent Development
Table 80. Pfizer Company Detail
Table 81. Pfizer Business Overview
Table 82. Pfizer Renal Cortical Necrosis Treatment Product
Table 83. Pfizer Revenue in Renal Cortical Necrosis Treatment Business (2018-2023) & (US$ Million)
Table 84. Pfizer Recent Development
Table 85. Novartis AG Company Detail
Table 86. Novartis AG Business Overview
Table 87. Novartis AG Renal Cortical Necrosis Treatment Product
Table 88. Novartis AG Revenue in Renal Cortical Necrosis Treatment Business (2018-2023) & (US$ Million)
Table 89. Novartis AG Recent Development
Table 90. Eisai Pharmaceuticals India Pvt. Ltd. Company Detail
Table 91. Eisai Pharmaceuticals India Pvt. Ltd. Business Overview
Table 92. Eisai Pharmaceuticals India Pvt. Ltd. Renal Cortical Necrosis Treatment Product
Table 93. Eisai Pharmaceuticals India Pvt. Ltd. Revenue in Renal Cortical Necrosis Treatment Business (2018-2023) & (US$ Million)
Table 94. Eisai Pharmaceuticals India Pvt. Ltd. Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Renal Cortical Necrosis Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Renal Cortical Necrosis Treatment Market Share by Type: 2022 VS 2029
Figure 3. Prednisolone Features
Figure 4. Aspirin Features
Figure 5. Sodium Bicarbonates Features
Figure 6. N-acetyl Cysteine Features
Figure 7. Statins Features
Figure 8. Others Features
Figure 9. Global Renal Cortical Necrosis Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Renal Cortical Necrosis Treatment Market Share by Application: 2022 VS 2029
Figure 11. Hospitals Case Studies
Figure 12. Cancer clinics Case Studies
Figure 13. Ambulatory Surgical Centers Case Studies
Figure 14. Others Case Studies
Figure 15. Renal Cortical Necrosis Treatment Report Years Considered
Figure 16. Global Renal Cortical Necrosis Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global Renal Cortical Necrosis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Renal Cortical Necrosis Treatment Market Share by Region: 2022 VS 2029
Figure 19. Global Renal Cortical Necrosis Treatment Market Share by Players in 2022
Figure 20. Global Top Renal Cortical Necrosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Cortical Necrosis Treatment as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Renal Cortical Necrosis Treatment Revenue in 2022
Figure 22. North America Renal Cortical Necrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. North America Renal Cortical Necrosis Treatment Market Share by Country (2018-2029)
Figure 24. United States Renal Cortical Necrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Renal Cortical Necrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Renal Cortical Necrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Renal Cortical Necrosis Treatment Market Share by Country (2018-2029)
Figure 28. Germany Renal Cortical Necrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Renal Cortical Necrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Renal Cortical Necrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Renal Cortical Necrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Renal Cortical Necrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Renal Cortical Necrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Renal Cortical Necrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Renal Cortical Necrosis Treatment Market Share by Region (2018-2029)
Figure 36. China Renal Cortical Necrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Japan Renal Cortical Necrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. South Korea Renal Cortical Necrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Renal Cortical Necrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. India Renal Cortical Necrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Australia Renal Cortical Necrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Renal Cortical Necrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Renal Cortical Necrosis Treatment Market Share by Country (2018-2029)
Figure 44. Mexico Renal Cortical Necrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Brazil Renal Cortical Necrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Renal Cortical Necrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Renal Cortical Necrosis Treatment Market Share by Country (2018-2029)
Figure 48. Turkey Renal Cortical Necrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Renal Cortical Necrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Allergan plc Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2018-2023)
Figure 51. Amgen Inc. Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2018-2023)
Figure 52. AstraZeneca plc Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2018-2023)
Figure 53. Baxter Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2018-2023)
Figure 54. Keryx Biopharmaceuticals, Inc Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2018-2023)
Figure 55. Teva Pharmaceutical Limited Inc Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2018-2023)
Figure 56. Pfizer Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2018-2023)
Figure 57. Novartis AG Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2018-2023)
Figure 58. Eisai Pharmaceuticals India Pvt. Ltd. Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 皮質グリッド電極の世界市場2023年：1×4電極コンタクト、4×4電極コンタクト、8×8電極コンタクト、その他
  • 世界のミネラル皮質粒子市場2022年：市場規模予測（～2028年）
  • 腫瘍壊死因子受容体スーパーファミリーメンバー1Aのグローバル市場展望 2023年-2029年：LY-3232094、EYS-606、SRT-100、その他
  • 末期腎疾患（ESRD）療法の世界市場インサイト・予測（～2028年）
  • 腫瘍壊死因子受容体スーパーファミリーメンバー18のグローバル市場展望 2023年-2029年：AMG-228、BMS-986156、FPA-154、GWN-323、INCAGN-1876、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8323 )"腎皮質壊死治療の世界市場2023年：プレドニゾロン、アスピリン、炭酸水素ナトリウム、N-アセチルシステイン、スタチン、その他" (英文：Global Renal Cortical Necrosis Treatment Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。